The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis
García-Arellano S, Hernández-Palma L, Cerpa-Cruz S, Sánchez-Zuno G, Herrera-Godina M, Muñoz-Valle J. The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis. Molecules 2021, 26: 4968. PMID: 34443554, PMCID: PMC8398282, DOI: 10.3390/molecules26164968.Peer-Reviewed Original ResearchConceptsSecretion of IL-25Peripheral blood mononuclear cellsMacrophage migration inhibitory factorIL-25IL-33IL-31Rheumatoid arthritisRA patientsPeripheral blood mononuclear cells of patientsPeripheral blood mononuclear cells of RA patientsAutoimmune inflammatory joint diseaseImmune-modulatory cytokinesBlood mononuclear cellsIL-33 secretionMigration inhibitory factorCytokine dysregulationSystemic inflammationInflammatory joint diseaseMononuclear cellsImmunomodulatory effectsStudy groupPatient treatmentInhibitory factorJoint destructionPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply